Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
24 studies found for:    Corticobasal Degeneration
Show Display Options
Download search resultsDownload the search results for:
Corticobasal Degeneration (24 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Completed
Has Results
A Pilot Trial of Lithium in Subjects With Progressive Supranuclear Palsy or Corticobasal Degeneration
Conditions: Progressive Supranuclear Palsy;   Corticobasal Degeneration
Intervention: Drug: Lithium
2 Completed Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy Volunteers
Conditions: Progressive Supranuclear Palsy;   Corticobasal Degeneration
Interventions: Drug: 18F-AV-1451;   Drug: florbetapir F18
3 Recruiting PROgressive Supranuclear Palsy CorTico-Basal Syndrome Multiple System Atrophy Longitudinal Study UK
Conditions: Progressive Supranuclear Palsy (PSP);   Corticobasal Degeneration;   Multiple System Atrophy (MSA)
Intervention:
4 Completed Repetitive Transcranial Magnetic Stimulation (TMS) for Progressive Supranuclear Palsy and Corticobasal Degeneration
Conditions: Progressive Supranuclear Palsy;   Corticobasal Degeneration;   Parkinsonism
Intervention:
5 Completed Electrical Polarization of the Brain in Corticobasal Syndrome
Condition: Corticobasal Syndrome
Intervention: Device: Phoresor II
6 Active, not recruiting 4 Repeat Tauopathy Neuroimaging Initiative
Conditions: Progressive Supranuclear Palsy;   Corticobasal Degeneration
Intervention: Other: Observational Study
7 Active, not recruiting Safety Study of TPI-287 to Treat CBS and PSP
Conditions: Primary Four Repeat Tauopathies (4RT);   Corticobasal Syndrome (CBS);   Progressive Supranuclear Palsy (PSP);   Corticobasal Degeneration (CBD)
Interventions: Drug: TPI 287 2 mg/m2;   Drug: TPI-287 20 mg/m2;   Drug: Placebo;   Drug: TPI-287 6.3 mg/m2
8 Active, not recruiting Davunetide (AL-108) in Predicted Tauopathies - Pilot Study
Conditions: Predicted Tauopathies, Including;   Progressive Supranuclear Palsy;   Frontotemporal Dementia With Parkinsonism Linked to Chromosome 17;   Corticobasal Degeneration Syndrome;   Progressive Nonfluent Aphasia
Interventions: Drug: davunetide (AL-108, NAP);   Drug: Placebo nasal spray
9 Recruiting 4-Repeat Tauopathy Neuroimaging Initiative - Cycle 2
Conditions: Corticobasal Degeneration (CBD);   Corticobasal Syndrome (CBS);   Cortical-basal Ganglionic Degeneration (CBGD);   Progressive Supranuclear Palsy (PSP);   Nonfluent Variant Primary Progressive Aphasia (nfvPPA);   Oligosymptomatic/Variant Progressive Supranuclear Palsy (o/vPSP)
Intervention: Other: Observational Study
10 Recruiting Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL)
Conditions: FTLD;   Progressive Supranuclear Palsy (PSP);   Frontotemporal Dementia (FTD);   Corticobasal Degeneration (CBD);   PPA Syndrome;   Behavioral Variant Frontotemporal Dementia (bvFTD);   Semantic Variant Primary Progressive Aphasia (svPPA);   Nonfluent Variant Primary Progressive Aphasia (nfvPPA);   FTD With Amyotrophic Lateral Sclerosis (FTD/ALS);   Amyotrophic Lateral Sclerosis (ALS);   Oligosymptomatic PSP (oPSP);   Corticobasal Syndrome (CBS)
Intervention:
11 Active, not recruiting Defining Phenotypes of Movement Disorders :Parkinson's Plus Disorders, PD,Essential Tremor, (ET),Cortical Basal Degeneration, (CBD),Multiple Systems Atrophy (MSA), Magnetoencephalography
Conditions: Essential Tremor;   Multiple System Atrophy;   Corticobasal Degeneration;   Supranuclear Palsy, Progressive
Intervention:
12 Completed Effects of Coenzyme Q10 in PSP and CBD
Conditions: Progressive Supranuclear Palsy;   Neurological Disorders
Intervention: Drug: CoQ10
13 Recruiting Safety, Tolerability and Efficacy of AVP-786 for the Treatment of Disinhibition
Condition: Disinhibition Syndrome
Interventions: Drug: AVP-786;   Drug: Placebo
14 Completed The Differential Diagnosis of Parkinson's Disease and Parkinsonism by Positron-emission Tomography
Condition: Parkinson's Disease
Intervention: Drug: 18F-FDG
15 Recruiting Study for the Early Diagnosis of Parkinson's Disease
Condition: Parkinson's Disease, Idiopathic
Intervention:
16 Recruiting Parkinson's Disease, Diagnostic Observations (PADDO)
Conditions: Parkinson's Disease;   Atypical Parkinsonism
Intervention:
17 Unknown  Innovative Biomarkers in Alzheimer's Disease and Frontotemporal Dementia (FTD): Preventative and Personalized
Condition: Alzheimer's Disease
Intervention:
18 Completed Study of Tongue Pressures
Conditions: Deglutition Disorder;   Healthy
Intervention:
19 Active, not recruiting The Sunnybrook Dementia Study: Mapping Brain Changes in Alzheimer's, Vascular and Other Dementias
Condition: Dementia
Intervention:
20 Recruiting Diagnosing Frontotemporal Lobar Degeneration
Conditions: Corticobasal Syndrome;   Progressive Supranuclear Palsy;   Behavioral Variant Frontotemporal Dementia;   Semantic Dementia;   Progressive Nonfluent Aphasia;   Amyotrophic Lateral Sclerosis and/or Frontotemporal Dementia
Intervention: Other: Observational Study

   Previous Page Studies Shown (1-20) Next Page (21-24) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.